Holger Zimmermann

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

Roy F. Chemaly, Andrew J. Ullmann, Susanne Stoelben et al. · New England Journal of Medicine · 2014 · 361 citations · Full text

The Human Papillomavirus Type 16 E6 Oncoprotein Can Down-Regulate p53 Activity by Targeting the Transcriptional Coactivator CBP/p300

Holger Zimmermann, Roland Degenkolbe, Hans‐Ulrich Bernard et al. · Journal of Virology · 1999 · 336 citations · Full text

Viral Replication, Pathology, Molecular Biology +18

The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase

Thomas Goldner, Guy Hewlett, Nicole Ettischer et al. · Journal of Virology · 2011 · 333 citations · Full text

Human Cytomegalovirus Replication, Viral Replication, Hcmv Dna +13

<i>In</i> <i>Vitro</i> and <i>In Vivo</i> Activities of the Novel Anticytomegalovirus Compound AIC246

Peter Lischka, Guy Hewlett, Tobias Wunberg et al. · Antimicrobial Agents and Chemotherapy · 2010 · 237 citations · Full text

Vitro Inhibitory Activity, Antiviral Compound, Medicine +11

First Report of Successful Treatment of Multidrug-Resistant Cytomegalovirus Disease with the Novel Anti-CMV Compound AIC246

Daniel Kaul, Susanne Stoelben, Eric Cober et al. · American Journal of Transplantation · 2011 · 159 citations

Successful Treatment, Neurovirology, Immunology +8